Literature DB >> 12524226

Cardiac ankyrin repeat protein (CARP) expression in human and murine atherosclerotic lesions: activin induces CARP in smooth muscle cells.

Vivian de Waard1, Tanja A E van Achterberg, Nicholas J Beauchamp, Hans Pannekoek, Carlie J M de Vries.   

Abstract

OBJECTIVE: Cardiac ankyrin repeat protein (CARP) is a transcription factor-related protein that has been studied most extensively in the heart. In the present study, we investigated the expression and the potential function of CARP in human and murine atherosclerosis. METHODS AND
RESULTS: CARP expression was observed by in situ hybridization in endothelial cells lining human atherosclerotic plaques, whereas lesion macrophages were devoid of CARP. Furthermore, we established that CARP mRNA and smooth muscle (SM) alpha-actin antigen both colocalized in a subset of intimal smooth muscle cells (SMCs), whereas no CARP mRNA was encountered in quiescent SMCs in the media. The CARP mRNA-expressing intimal SMCs were distinct from intimal SMCs that synthesized the activation marker osteopontin or proliferating cell nuclear antigen. In addition, we showed that activin A, a member of the TGFbeta superfamily that prevents SMC-rich lesion formation, induced CARP mRNA expression in cultured SMCs.
CONCLUSIONS: Based on our data and the knowledge that CARP reduces the proliferation of cultured SMCs, we propose that CARP is involved in inhibition of vascular lesion formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12524226     DOI: 10.1161/01.atv.0000042218.13101.50

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

1.  Differences in genetic signaling, and not mechanical properties of the wall, are linked to ascending aortic aneurysms in fibulin-4 knockout mice.

Authors:  Jungsil Kim; Jesse D Procknow; Hiromi Yanagisawa; Jessica E Wagenseil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-01       Impact factor: 4.733

Review 2.  Multifunctional protein: cardiac ankyrin repeat protein.

Authors:  Na Zhang; Xiao-Jie Xie; Jian-An Wang
Journal:  J Zhejiang Univ Sci B       Date:  2016-05       Impact factor: 3.066

3.  Global deletion of Ankrd1 results in a wound-healing phenotype associated with dermal fibroblast dysfunction.

Authors:  Susan E Samaras; Karinna Almodóvar-García; Nanjun Wu; Fang Yu; Jeffrey M Davidson
Journal:  Am J Pathol       Date:  2014-11-18       Impact factor: 4.307

Review 4.  Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification.

Authors:  Hyun-Ju Cho; Hyun-Jai Cho; Hyo-Soo Kim
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

5.  Double missense mutations in cardiac myosin-binding protein C and myopalladin genes: A case report with diffuse coronary disease, complete atrioventricular block, and progression to dilated cardiomyopathy.

Authors:  Sandra Mastroianno; Pietro Palumbo; Stefano Castellana; Maria Pia Leone; Raimondo Massaro; Domenico Rosario Potenza; Tommaso Mazza; Aldo Russo; Marco Castori; Massimo Carella; Giuseppe Di Stolfo
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-09-16       Impact factor: 1.468

6.  Aging modulates the effects of ischemic injury upon mesenchymal cells within the renal interstitium and microvasculature.

Authors:  Isaac W Shaw; Eoin D O'Sullivan; Angela O Pisco; Gary Borthwick; Kevin M Gallagher; Bruno Péault; Jeremy Hughes; David A Ferenbach
Journal:  Stem Cells Transl Med       Date:  2021-05-05       Impact factor: 7.655

Review 7.  Collateral circulation: past and present.

Authors:  Wolfgang Schaper
Journal:  Basic Res Cardiol       Date:  2008-12-20       Impact factor: 17.165

8.  The muscle ankyrin repeat proteins CARP, Ankrd2, and DARP are not essential for normal cardiac development and function at basal conditions and in response to pressure overload.

Authors:  Marie-Louise Bang; Yusu Gu; Nancy D Dalton; Kirk L Peterson; Kenneth R Chien; Ju Chen
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.